TNGX
Price
$11.89
Change
-$0.43 (-3.49%)
Updated
Feb 5, 03:57 PM (EDT)
Capitalization
1.66B
53 days until earnings call
Intraday BUY SELL Signals
TRDA
Price
$9.87
Change
-$0.95 (-8.78%)
Updated
Feb 5, 03:54 PM (EDT)
Capitalization
413.15M
41 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

TNGX vs TRDA

Header iconTNGX vs TRDA Comparison
Open Charts TNGX vs TRDABanner chart's image
Tango Therapeutics
Price$11.89
Change-$0.43 (-3.49%)
Volume$4.41K
Capitalization1.66B
Entrada Therapeutics
Price$9.87
Change-$0.95 (-8.78%)
Volume$200
Capitalization413.15M
TNGX vs TRDA Comparison Chart in %
TNGX
Daily Signal:
Gain/Loss:
TRDA
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
TNGX vs. TRDA commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TNGX is a StrongBuy and TRDA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 05, 2026
Stock price -- (TNGX: $12.32 vs. TRDA: $10.82)
Brand notoriety: TNGX and TRDA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: TNGX: 77% vs. TRDA: 91%
Market capitalization -- TNGX: $1.66B vs. TRDA: $413.15M
TNGX [@Biotechnology] is valued at $1.66B. TRDA’s [@Biotechnology] market capitalization is $413.15M. The market cap for tickers in the [@Biotechnology] industry ranges from $119.38B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

TNGX’s FA Score shows that 0 FA rating(s) are green whileTRDA’s FA Score has 0 green FA rating(s).

  • TNGX’s FA Score: 0 green, 5 red.
  • TRDA’s FA Score: 0 green, 5 red.
According to our system of comparison, both TNGX and TRDA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TNGX’s TA Score shows that 5 TA indicator(s) are bullish while TRDA’s TA Score has 1 bullish TA indicator(s).

  • TNGX’s TA Score: 5 bullish, 5 bearish.
  • TRDA’s TA Score: 1 bullish, 6 bearish.
According to our system of comparison, TNGX is a better buy in the short-term than TRDA.

Price Growth

TNGX (@Biotechnology) experienced а +10.20% price change this week, while TRDA (@Biotechnology) price change was -2.96% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.81%. For the same industry, the average monthly price growth was +0.47%, and the average quarterly price growth was +32.90%.

Reported Earning Dates

TNGX is expected to report earnings on Mar 30, 2026.

TRDA is expected to report earnings on Mar 18, 2026.

Industries' Descriptions

@Biotechnology (-3.81% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TNGX($1.66B) has a higher market cap than TRDA($413M). TNGX YTD gains are higher at: 39.052 vs. TRDA (5.253). TNGX has higher annual earnings (EBITDA): -107.91M vs. TRDA (-117.36M). TRDA has more cash in the bank: 327M vs. TNGX (153M). TNGX has less debt than TRDA: TNGX (34.8M) vs TRDA (52.4M). TNGX has higher revenues than TRDA: TNGX (66.5M) vs TRDA (61.5M).
TNGXTRDATNGX / TRDA
Capitalization1.66B413M402%
EBITDA-107.91M-117.36M92%
Gain YTD39.0525.253743%
P/E RatioN/A10.26-
Revenue66.5M61.5M108%
Total Cash153M327M47%
Total Debt34.8M52.4M66%
TECHNICAL ANALYSIS
Technical Analysis
TNGXTRDA
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
88%
Momentum
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 8 days ago
85%
Declines
ODDS (%)
Bearish Trend 11 days ago
90%
Bearish Trend 2 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
Aroon
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
TNGX
Daily Signal:
Gain/Loss:
TRDA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
USLUX21.700.16
+0.74%
US Global Investors Global Luxury Goods
EATVX46.450.05
+0.11%
Eaton Vance Tx-Mgd Value A
FTADX60.04N/A
N/A
Fidelity Advisor International Discv M
DESCX24.71-0.07
-0.28%
DWS Enhanced Core Equity C
LCGFX28.53-0.32
-1.11%
William Blair Large Cap Growth I

TNGX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TNGX has been loosely correlated with TERN. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if TNGX jumps, then TERN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TNGX
1D Price
Change %
TNGX100%
-1.83%
TERN - TNGX
52%
Loosely correlated
-6.39%
ERAS - TNGX
50%
Loosely correlated
+6.19%
TRDA - TNGX
50%
Loosely correlated
-8.23%
PRAX - TNGX
49%
Loosely correlated
-2.31%
GPCR - TNGX
47%
Loosely correlated
-3.01%
More

TRDA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRDA has been closely correlated with CGEM. These tickers have moved in lockstep 75% of the time. This A.I.-generated data suggests there is a high statistical probability that if TRDA jumps, then CGEM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRDA
1D Price
Change %
TRDA100%
-8.23%
CGEM - TRDA
75%
Closely correlated
-6.66%
TERN - TRDA
74%
Closely correlated
-6.39%
STRO - TRDA
74%
Closely correlated
+0.40%
ATOS - TRDA
73%
Closely correlated
-4.34%
ACET - TRDA
72%
Closely correlated
-3.51%
More